Cargando…

The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

BACKGROUND: Mantle cell lymphoma (MCL) is an incurable B cell-derived malignant tumor with a median overall survival of 4–5 years. Mer tyrosine kinase (MerTK) has been reported to be aberrantly expressed in leukemia, melanoma, and gastric cancer, and plays a pivotal role in the process of oncogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Cunzhen, Li, Xiangqun, Wang, Xiaogan, Ding, Ning, Ping, Lingyan, Shi, Yunfei, Mi, Lan, Lai, Yumei, Song, Yuqin, Zhu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859520/ https://www.ncbi.nlm.nih.gov/pubmed/29554921 http://dx.doi.org/10.1186/s13045-018-0584-6

Ejemplares similares

The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma
por: Li, Jiao, et al.
Publicado: (2022)

The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages
por: Ping, Lingyan, et al.
Publicado: (2017)

Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated
Publicado: (1991)

Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma
por: Wang, Michael L., et al.
Publicado: (2023)

PBF, a Proto-oncogene in Esophageal Carcinoma
por: Lian, Shi-hai, et al.
Publicado: (2019)

Proto-oncogene tyrosine-protein kinase SRC (Src) inhibition in microglia relieves neuroinflammation in neuropathic pain mouse models
por: Cai, Yuanxing, et al.
Publicado: (2021)

The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
por: Stachelscheid, Johanna, et al.
Publicado: (2021)

Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
por: Lantermans, Hildo C., et al.
Publicado: (2020)

Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors
por: Gao, Hongye, et al.
Publicado: (2023)

Role of proto-oncogene activation in carcinogenesis.
por: Anderson, M W, et al.
Publicado: (1992)

The Biology of the Ets1 Proto-Oncogene
por: Dittmer, Jürgen
Publicado: (2003)

Allosteric activation of proto-oncogene kinase Src by GPCR–beta-arrestin complexes
por: Pakharukova, Natalia, et al.
Publicado: (2021)

Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
por: Di, Mengyang, et al.
Publicado: (2022)

Phosphorylation of Ack1 by the Receptor Tyrosine Kinase Mer
por: Hayashi, Samantha Y., et al.
Publicado: (2023)

Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
por: Brown, Geoffrey
Publicado: (2021)

Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma
por: Axelrod, M, et al.
Publicado: (2014)

Dihydroorotate dehydrogenase inhibition acts synergistically with tyrosine kinase inhibitors to induce apoptosis of mantle cell lymphoma cells
por: Eriksen‐Gjerstad, May, et al.
Publicado: (2022)

HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton’s Tyrosine Kinase Inhibitor Ibrutinib
por: Lu, Ziwen, et al.
Publicado: (2022)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Roles of the RET Proto-oncogene in Cancer and Development
por: Takahashi, Masahide, et al.
Publicado: (2020)

Terpinen-4-ol Induces Ferroptosis of Glioma Cells via Downregulating JUN Proto-Oncogene
por: Cao, Wenpeng, et al.
Publicado: (2023)

Relapsed anaplastic lymphoma kinase-positive large B-cell lymphoma expressed cluster of differentiation 4 and cytokeratin: An initially misdiagnosed case corrected by immunoglobulin κ locus gene rearrangement detection
por: Shi, Yunfei, et al.
Publicado: (2017)

Structural insights into the inhibited states of the Mer receptor tyrosine kinase
por: Huang, Xudong, et al.
Publicado: (2009)

Mechanisms of autoimmunity in mice lacking the mer membrane tyrosine kinase
por: Cohen, PL, et al.
Publicado: (2004)

Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene
por: Mendes Oliveira, Duarte, et al.
Publicado: (2018)

Proto-oncogene FAM83A contributes to casein kinase 1–mediated mitochondrial maintenance and white adipocyte differentiation
por: Huang, Kuilong, et al.
Publicado: (2022)

The Expression and Clinical Significance of Different Forms of Mer Receptor Tyrosine Kinase in Systemic Lupus Erythematosus
por: Zhu, Huaqun, et al.
Publicado: (2014)

Activation of proto-oncogenes in human and mouse lung tumors.
por: Reynolds, S H, et al.
Publicado: (1991)

Analyses of domains and domain fusions in human proto-oncogenes
por: Liu, Qi, et al.
Publicado: (2009)

The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs
por: Nairismägi, Maarja-Liisa, et al.
Publicado: (2013)

The impact of the MYB-NFIB fusion proto-oncogene in vivo
por: Mikse, Oliver R., et al.
Publicado: (2016)

Distribution of RET proto‐oncogene variants in children with appendicitis
por: Schultz, Jurek, et al.
Publicado: (2022)

Laser nanostructured gold biosensor for proto-oncogene detection
por: Hughes, Cian, et al.
Publicado: (2023)

Genome-Wide Gene Expression Analysis Identifies the Proto-oncogene Tyrosine-Protein Kinase Src as a Crucial Virulence Determinant of Infectious Laryngotracheitis Virus in Chicken Cells
por: Li, Hai, et al.
Publicado: (2015)

Correction to: Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene
por: Oliveira, Duarte Mendes, et al.
Publicado: (2018)

Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases
por: Alvarez-Palomo, Belen, et al.
Publicado: (2019)

P1157: REAL-WORLD TREATMENT PATTERNS AND COMPARATIVE EFFECTIVENESS OF BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH MANTLE CELL LYMPHOMA
por: Shah, B., et al.
Publicado: (2022)

miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma
por: McGirt, Laura Y., et al.
Publicado: (2013)

Bortezomib enhances the anti-cancer effect of the novel Bruton’s tyrosine kinase inhibitor (BGB-3111) in mantle cell lymphoma expressing BTK
por: Wang, Xianhuo, et al.
Publicado: (2021)

Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents
por: Jain, Neeraj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ja2rvcd0kgebjrf8vf1oivlhc